Iron regulatory proteins (IRPs) control the translation of proteins involved in iron uptake, storage and utilization by binding to specific noncoding sequences of the corresponding mRNAs known as iron-responsive elements (IREs). This strong interaction assures proper iron homeostasis in animal cells under iron shortage. Conversely, under iron-replete conditions, IRP1 binds a [4Fe-4S] cluster and functions as cytosolic aconitase. Regulation of the balance between the two IRP1 activities is complex, and it does not depend only on iron availability. Here, we report the crystal structure of human IRP1 in its aconitase form. Comparison with known structures of homologous enzymes reveals well-conserved folds and active site environments with significantly different surface shapes and charge distributions. The specific features of human IRP1 allow us to propose a tentative model of an IRP1-IRE complex that agrees with a range of previously obtained data.
Introduction
Iron is essential to all mammalian cells, and, after being absorbed from the diet, it is distributed throughout the body, with a large proportion directed to the oxygen binding site of hemoglobin. Any intestinal absorption imbalance or defective distribution results in disorders such as hemochromatosis or anemia. Regulatory mechanisms of iron absorption are beginning to be understood (Hentze et al., 2004) . Extracellular iron normally circulates in the plasma bound to transferrin, and cellular iron distribution must be properly managed to avoid deleterious accumulations or shortages as observed in the disorders mentioned above. One major regulatory mechanism of cellular iron metabolism involves two cytosolic iron regulatory proteins (IRP1 and IRP2) that bind to specific stem-loop structures, the iron-responsive elements (IREs), located at either the 5 0 or the 3 0 end of the mRNA of proteins like ferritin and transferrin receptor (Pantopoulos, 2004) .
Unlike IRP2, IRP1 has two activities: it can either bind to IREs, or it can assemble a [4Fe-4S] cluster and function as a cytosolic aconitase (cAcn), catalyzing the conversion of citrate to isocitrate (Haile et al., 1992) . The actual involvement of IRP1 in iron metabolism remains to be fully established, and its capacity to substitute for IRP2 in the regulation of iron homeostasis is being addressed with IRP2-deficient mice (Cooperman et al., 2005; Galy et al., 2005) . Under normal conditions, IRP1 seems to be mainly present as cAcn in tissues (MeyronHoltz et al., 2004) . The enzymatic form is likely to contribute to cell defense against oxidative stress by providing the isocitrate substrate to NADP-dependent isocitrate dehydrogenase, which is one of the major producers of NADPH in the cytosol (Lee et al., 2002) . NADPH is used by glutathione reductase to regenerate reduced glutathione, which may be oxidized by glutathione peroxidase to remove oxidative stress-induced H 2 O 2 .
A variety of cellular responses to changing environmental conditions are associated with a switch of IRP1 activity between its two active forms resulting from the assembly/disassembly of the [4Fe-4S] cluster. Cluster disassembly triggers the conversion to the IRE binding form upon iron starvation or under oxidative stress produced by reactive oxygen (Pantopoulos et al., 1997) or nitrogen species (Drapier et al., 1993) . As apo-protein, IRP1 enhances iron mobilization and signals the need for more uptake by both blocking the translation of ferritin mRNA and stabilizing the transferrin receptor mRNA (Haile et al., 1992) . However, an excess of cellular iron may be toxic due to its participation in Fenton-type redox chemistry, leading to the production of highly reactive hydroxyl radicals (Hentze et al., 2004) . Because iron deficiency also affects the proper functioning of the cell, the IRE binding activity of IRP1 requires strict regulation.
If many of the enzymatic activities important for the biological synthesis of iron-sulfur centers have been identified (Lill and Muhlenhoff, 2005) , little is known about the cellular factors that directly trigger the ''iron-sulfur switch'' of IRP1 and its detailed mechanism, except for evidence that this posttranscriptional event is associated with sizeable structural changes affecting the entire protein (Brazzolotto et al., 2002) . One major obstacle to fully understand the unusual behavior of this bifunctional protein is the lack of a eukaryotic IRP structure. We have recently communicated the crystallization of human IRP1 in its aconitase form (Dupuy et al., 2005) . Here, we report the structure of this protein in two different crystal forms, we analyze the major differences with mitochondrial and bacterial aconitases, and we describe the results of manual docking of an IRE into the IRP1 structure. To our knowledge, this is the first structure of a mammalian IRP. The model reveals some of the key features that allow this protein to switch activities depending on cell requirements.
Results

Structure Description
The fold of the cAcn form of human IRP1 is similar to that of the w20% smaller mammalian mitochondrial enzymes (mAcn) (Lauble et al., 1992; Robbins and Stout, 1989) , in spite of an overall sequence identity of only about 22%. Each protein is composed of four globular domains, with an extended linker segment located at the protein surface that joins domains 3 and 4 (Figure 1 ). The [4Fe-4S] cluster lies close to the center of the molecule at the interface of the four domains. We have solved the structures of three crystallographically independent molecules of human cAcn: one in an orthorhombic (C222 1 ) and two in a monoclinic crystal (P2 1 ) form. A Zn site is present only in the C222 1 form (Dupuy et al., 2005) . As this site is involved in crystal packing, no functional relevance can be attributed to it.
Superposition of the refined models of the two cAcn crystal forms gives rms deviations that vary from 0.22 Å to 0.35 Å when it is applied domain by domain. If entire molecules are superimposed, significantly higher rms deviations of 0.39 Å and 0.52 Å are obtained. A comparison with bovine mAcn (Table 1) shows that more than 90% of the Ca atoms of its domains 2, 3, and 4 can be closely superimposed to human cAcn, although the sequence identity is only about 30%. All insertions/ deletions and other local differences are indicated in the structure-based sequence alignment given in Figure 2. Human IRP2, which is 61% identical to IRP1, is also included in this figure. The sequences of other mammalian IRP1s are more than 92% identical to the human protein, whereas chicken IRP1 is 87% identical. Because, in addition, most of the substitutions are conservative and there are no insertions or deletions, all of these IRP1s are expected to have essentially the same structure.
A different fold is observed for the N-terminal region of domain 1 of cAcn (residues 1-33) when compared to mAcn. This may be described as a small subdomain that comprises two short 3 10 helices and the two antiparallel b strands b1 and b2 ( Figures 1B, 1C , and 2). Accordingly, the first long a helix of mAcn is absent from cAcn, whereas the second one (a1 in cAcn) is much longer. This is followed by a first insertion (residues 47-72) that includes helices a2 and a3. Two additional insertions in domain 1 (residues 103-113 and 188-196) comprise an extension of helix a4, the short 3 10 helix h4, and the two antiparallel b strands b7 and b8 that pack against the N-terminal subdomain. Domain 3 contains two insertions: residues 395-425, ending with b strands b18 and b19, and residues 515-521, containing helix a18. Another long insertion is located in domain 4 (residues 686-708) and comprises helices a25 and h12. In addition, the linker in cAcn is about 20 residues longer than in mAcn, and it is also more structured. Because all of these insertions are exposed, the shapes of cAcn and mAcn are significantly different, which explains the dissimilar RNA binding properties of the two proteins.
A high structural similarity also exists between about 66% of domain 4 of cAcn and 95% of the small subunit of Pyrococcus horichoshii isopropylmalate isomerase (Ipmi) (Yasutake et al., 2004) , another member of the Fe-S isomerase family (Gruer et al., 1997) . The structural superposition is not as good between cAcn and aconitase B (AcnB) from Escherichia coli. This protein has an extra N-terminal HEAT-like region, a different domain order (Table 1) , and a short linker between its second and third domains (Williams et al., 2002) . About 86% of the Ca atoms of its relatively short domain 3 and 91% of its domain 5 can be closely superimposed to cAcn domains 1 and 3, respectively. Significantly lower values are obtained when the other two cAcn domains are compared.
Substrate Accessibility
The crystal structure is in a closed conformation that does not allow access and release of the tricarboxylic acid substrates and products to and from the [4Fe-4S]-containing active site of cAcn. Access to the active site may be generated through a movement of domain 4 with respect to the other domains, as proposed for mAcn (Beinert et al., 1996) ; it is therefore relevant to analyze the interdomain contacts ( Table 2 ). The main body of domain 4, to be called domain 4a, is composed of residues 660-865 and consists of a b barrel next to a mostly a-helical region. This subdomain makes an extensive, mainly polar contact interface with the three N-terminal domains. A C-terminal a-helical appendix (residues 866-889) called domain 4b is packed against domain 1, but here the contacts are mostly hydrophobic in nature. Because exposure of a hydrophobic surface to the solvent is thermodynamically unfavorable, the C-terminal appendix might serve as an anchor during the proposed movement of domain 4.
An electrostatic potential map reveals a remarkable concentration of positive charges at the surface of domains 1-3 facing domain 4a ( Figure 1D ), between two extensive negatively charged patches that are located in domains 1 and 3, respectively. There is a partially connected network of hydrophilic cavities that follows the long positive patch at the domain interface ( Figure 1E ). This network is likely to be involved in guiding the negatively charged substrates and products citrate, cis-aconitate, and isocitrate to and from the active site. A small rotation of domain 4 about some point in the hydrophobic contact interface, which is formed between its C-terminal appendix and domain 1, would suffice to expand the cavities enough to allow access of the substrates to the active site.
The positive patch contains residues from each of the three N-terminal domains that can be separated into two groups. The first one involves four basic residues, H126, H207, R536, and R541, that, together with two basic residues from domain 4a, R713 and R780, surround the substrate binding site. These six residues are conserved in the mitochondrial and bacterial aconitase sequences and also in IRP2. The second group involves five more distant basic residues, R149, R153, K266, R269, and R375, which are invariant in IRP2 but are not conserved in bovine or in pig mAcn or in E. coli AcnB. A comparison of the surface charge distributions of cAcn and mAcn (data not shown) confirms that significant differences between the two proteins exist outside the active site pocket.
The Active Site All residues surrounding the active site cavity are strictly conserved between cAcn, mAcn, and AcnB. It is thus not Figure S1 ), with domain 4 in front of domains 1-3. Regions with the same fold as in bovine mitochondrial aconitase (mAcn) are shown in light gray. Two phosphorylation sites, S138 and S711 (Eisenstein et al., 1993) , are shown in violet, whereas a star marks the location of a 73 residue insertion in human IRP2. surprising that the active site structures are essentially the same. The cAcn crystals used in this study grew from a citrate-containing solution, and we expected, therefore, to be able to detect bound substrate. However, for one of the cAcn molecules in the asymmetric unit of the monoclinic crystal form, no clear electron density corresponding to a substrate molecule was observed; only a water or hydroxide ligand could be assigned to the non-cysteine bound Fe of the cluster, completing its tetrahedral coordination ( Figure 3A ). For the other molecule, three isolated density features were observed ( Figure 3B ), two of which are compatible with two carboxylate groups of the substrate, whereas the third one may be assigned to both the third carboxylate and an iron bound water ligand. The location of the three electron density peaks cannot be explained by the known isocitrate and citrate binding modes observed for mAcn (Lauble et al., 1992; Lloyd et al., 1999) . It is likely that a mixture of different binding modes of citrate, isocitrate, and/or cis-aconitate is present in the crystal, precluding an accurate modeling of these molecules.
Docking of an Iron-Responsive Element
Previous IRE docking studies have been attempted by using the structure of mAcn as a model for human IRP1 (Gegout et al., 1999; Paraskeva and Hentze, 1996) . However, the shape of cAcn is significantly different from that of mAcn ( Figures 1B and 1C) , which led us to try the docking of IRE on the actual IRP1 structure. For the sake of simplicity, domains 1-3 were fixed, and only rigid body movements were applied to domain 4a of IRP1 and to the IRE, which was taken from the NMR structure of a truncated and slightly modified human ferritin IRE fragment (Addess et al., 1997) . In this process, we used the information obtained by Schlegl and coworkers, who were able to localize the parts of homologous transferrin receptor IREs that are protected from enzymatic or chemical cleavage upon binding to IRP1 (Schlegl et al., 1997) (Figure 4A ). Additional constraints came from the reported involvement or protection of several amino acid residues in the IRE complex, based on site-directed mutagenesis (Butt et al., 1996; Kaldy et al., 1999; Philpott et al., 1994) , crosslinking (Basilion et al., 1994) , and footprinting studies of IRP1 (Gegout et al., 1999) (Table 3) . Among the involved amino acids, residues H126, R149, R536, R541, and R780 are part of the positive patch discussed above at the interface between domain 4 and domains 1-3 ( Figure 1D ).
There is a striking similarity in the shape of the domain 4a surface that faces domains 1-3 and a part of the surface of the IRE ( Figure 4B ), suggesting that, in the complex, the latter may replace domain 4a. Because of the pseudo 2-fold symmetry of the IRE structure, it can be superimposed in two ways to domain 4a, with the loop containing bases 13-18 pointing in opposite directions. In one orientation, D137 and K141, which are exposed to proteases in the IRE-IRP1 complex (Gegout et al., 1999) , are close to the 3 0 end of the docked IRE, whereas, in the other orientation, they are highly exposed ( Figure 4C ). Taking into account additional docking constraints (Table 3), and assuming an anchoring function of the C-terminal appendix during the rearrangement of domain 4, the orientation with the loop pointing downward in Figure 4C is preferred.
The docked IRE packs closely against R149, R153, R269, R536, and R541 of domains 1-3 ( Figure 4D ). Some of these residues were already predicted to be involved in IRE binding (Table 3) . However, a significant local structural change of the IRE is required to allow its interaction with S127 (Basilion et al., 1994) . If the structure of the truncated IRE is extended in the 5 0 direction, it could also contact R375 and K266. F88, a residue conserved in IRP2 (but not in mAcn), could stack with one or two bases in the IRE loop. In addition, the exposed F399 and F538 that are conserved in IRP2 (but not in mAcn) might interact with some of the bases that are located in the 5 0 end of the IRE. However, these bases are not present in the truncated NMR structure (Addess et al., 1997) . Figure 4E depicts a rigid body movement of domain 4a consisting of a 21º rotation and a center of mass translation of 22 Å . This requires a rearrangement of a30 in order to connect the last residue of domain 4a to the fixed C-terminal anchor. The combined movements expose R721, R728, R732, and R780, which may directly interact with the negatively charged phosphates of the IRE ( Figure 4F ). Our docking model satisfies the predicted contact of the 685-689 region of domain 4 with the IRE loop (C13-C18) and of its 732-737 region with the conserved cytidine bulge (C7) (Kaldy et al., 1999) , although a specific contact with C7 has been questioned more Secondary structure elements are indicated with spirals for a helices and 3 10 helices and arrows for b strands; they are labeled for cAcn on the top line (using h for 3 10 helices) and are shown for mAcn on the bottom line. Gaps are shown as dots. XXX corresponds to a 73 amino acid insertion in IRP2; ZZZ indicates regions of mAcn for which there is no close structural similarity with cAcn.
recently (Meehan and Connell, 2001) . Additional data supporting our model are provided in the Supplemental Data (available with this article online).
Discussion
To our knowledge, this is the first report of the structure of a mammalian cytosolic aconitase (cAcn/IRP1). The structure may be used as a basis to investigate which changes allow it to bind IREs and turn it into a regulator of the translation of mRNAs coding for proteins that are involved in iron homeostasis. The structural comparison of the three cAcn models obtained here shows smaller rms deviations for a domain-by-domain superposition than for a superposition of the entire molecule. This indicates that different crystal packing interactions have (A) Secondary structure of the IRE (Addess et al., 1997) . Bases circled in red and riboses highlighted by a blue dot are predicted to be in contact with IRP1 (Schlegl et al., 1997) .
(B) Stereopicture of the superposition of the IRE (orange) with domain 4 (green), in the same view as Figure 1B . (C) IRE docking against domains 1-3. Yellow, hydrophobic patch; green, involved in IRE binding or protected against proteolysis in the IRP1-IRE complex (Table 3) ; pink, aromatic residues; red, exposed upon IRE binding (Gegout et al., 1999) . (D) Same view, with electrostatic potential map colored as in Figure 1D .
(E) View of the entire IRP1-IRE model in the same view as Figure 1A , with colors as in (C).
(F) Docking of domain 4 against IRE, with colors as in (C) and (D).
caused small rigid body movements of the domains with respect to each other. Such movements may reflect the dynamic association of the domains in solution, and they suggest their possible participation in the release of the [4Fe-4S] cluster to convert the protein to the metalfree regulatory form. The structure of cAcn/IRP1 shows a network of partially connected hydrophilic cavities at the interface of domain 4 with the other domains ( Figure 1E ). This may become a wider tunnel after a small movement of domain 4. The highly negatively charged citrate, cis-aconitate, and isocitrate substrates and products may thus gain access to and exit from the active site following a long patch of positively charged residues at the domain interface ( Figure 1D ). In spite of its similar structure, mitochondrial aconitase may have a different substrate access pathway because, except for the substrate binding cavity, there are no conserved amino acid residues between cAcn and mAcn involved in the positive interdomain surface patches. On the other hand, all of these residues are conserved in IRP2, suggesting that they might interact with the negatively charged phosphate groups of the recognized IREs.
A reorientation of specific amino acid side chains may also play a role in allowing substrate access to the active site. In fact, the different occupation of the substrate cavity that is observed for the two cAcn molecules of the monoclinic crystal form could be due to a reorientation of R541. The electron density map suggests that this residue is partially disordered, with a significantly larger fraction pointing to the substrate cavity in molecule 2 ( Figure 3B ). This corresponds to the conformation found for mAcn in the isocitrate and citrate complexes (Lauble et al., 1992; Lloyd et al., 1999) . In the other orientation, which appears to be the major one in molecule 1 and also in the C222 1 crystal form, R541 cannot interact with the substrate, and it leaves open a narrow tunnel connecting the active site and the molecular surface ( Figures 1E and 3A) . A similar rearrangement of the corresponding Arg residue has been observed for mAcn in the absence of substrate or inhibitor molecules (Lauble and Stout, 1995) . The apparent disorder of this residue in cAcn may also explain why the substrate/product electron density is not better defined. Clearly, more studies are needed to obtain better structural information on substrate binding to cAcn and to verify whether, as expected, it has the same catalytic mechanism as mAcn.
Another question that may be addressed here is why IRP2 does not display aconitase activity, in spite of its 61% sequence identity with IRP1 (Guo et al., 1995) . A major difference is the 73 residue insertion in domain 1 (Figure 2 ) that is thought to form an additional domain in IRP2 (Pantopoulos, 2004) . There is no evidence for the presence of a [4Fe-4S] cluster in IRP2. Moreover, S778 of IRP1, which in mAcn is proposed to provide an alkoxyde that removes the Ca proton during dehydration of the citrate substrate (Beinert et al., 1996) (see also Figure 3) , is substituted by asparagine in IRP2. Both the replacement of the putative catalytic base by a bulkier residue and the absence of the cluster are sufficient to explain the absence of aconitase activity. A further comparison of residues situated around the [4Fe-4S] cavity in IRP1 shows substitution in IRP2 of I176 by methionine and of S441 by cysteine (Figure 3 ). The former replacement may leave insufficient space for a cluster to be present in IRP2, whereas the latter one points at the possibility that C437, one of the cluster ligands, forms a disulfide bond with C441 in IRP2 (IRP1 numbering), which would also prevent cluster binding. In the absence of a cluster, simple rotations of the side chains of C503 and C506 would allow for disulfide bond formation between these residues as well. A crystal structure of IRP2 is needed to dismiss or confirm these hypotheses.
A unique feature of human cAcn with respect to bovine and pig mAcn is the presence of a hydrophobic contact interface between the C-terminal appendix of domain 4 and helices a4 and a7 of domain 1 (Table 2) that may define an anchor and a hinge region for the domain 4 rigid body rotations that are putatively involved in substrate trafficking and IRE binding ( Figure 4C ). Another important difference is a long insertion in domain 4 of cAcn that includes helix a25 (Figures 1B and 2 ). This insertion is directly involved in the structural superposition of the loop region of human ferritin IRE and domain 4a ( Figure 4B ). The absence of these features in mAcn may be responsible for the apparent inability of this enzyme to bind efficiently to mRNA. Although it has been reported that bacterial AcnB, which is also different in this respect, is capable of binding to IRE-like stemloop RNA structures, it does it with association constants that are many orders of magnitude lower than the ones of human IRP1 (Williams et al., 2002) . Yeast mAcn, which is 68% identical to bovine mAcn, is involved in stabilizing mitochondrial DNA (Chen et al., 2005) , suggesting that it may interact with double-stranded nucleic acids. Considering that the IRE stem consists mainly of double-stranded RNA (Figure 4) , it remains to be investigated whether the surfaces of AcnB and yeast mAcn involved in DNA/RNA binding interactions are the same or different from those of human IRP1.
Circular dichroism studies have shown that removal of both the [4Fe-4S] cluster and the IRE from human cAcn/IRP1 leads to loss of some of the secondary structure, and small-angle neutron scattering studies have found increasing values for the radii of gyration of the series cAcn, IRP1-IRE complex, and apoenzyme (Brazzolotto et al., 2002), indicating significant conformational Philpott et al., 1994 R536, R541, R780 Decreased IRE binding in mutants Philpott et al., 1994; Butt et al., 1996 121-130 S127 is crosslinked to IRE Basilion et al., 1994 685-689, 732-737 Decreased IRE binding in mutants Kaldy et al., 1999 K79, D87, R101, D102, K105, K106, D125, R149, E155, R187, R721, R728, R732, D751 Protected against proteolysis in complex Gegout et al., 1999 differences between these forms. In the model reported here, we treated the IRE NMR structure as a rigid body and only introduced a simple rigid body rearrangement of domain 4a while keeping domains 1-3 fixed. However, it is very likely that there will be local structural adaptations of both IRP1 and the IRE. At any rate, our tentative model is consistent with most of the results that have been reported in the literature. Furthermore, the unexpected shape similarity between domain 4a and a region of the IRE ( Figure 4B ) suggests that the structural changes might be relatively small. A similar example of ''molecular mimicry'' is the close resemblance of the tRNA in a complex with elongation factor Tu to three domains of the translocation factor EF-G (Nissen et al., 1995) . A crystal structure of the actual IRP1-IRE complex will be useful to assess the quality of our tentative model, to describe the interaction between the two molecules in more detail, and to understand better why no IRE binding is possible when the iron-sulfur cluster is present. IRP1 contains two phosphorylation sites, at S138 and S711, that may regulate the relative concentration of the cAcn and IRE binding forms in vivo (Eisenstein et al., 1993) . Accordingly, Fillebeen et al. (2003) have shown that the phosphomimetic S138E mutation results in loss of the aconitase activity, and that the mutant protein is much more sensitive to iron-dependent proteolytic degradation than native IRP1. Also, phosphorylation of S711 was observed upon cell activation with phorbol 12-myristate 13-acetate, whereas the S711E phosphomimetic mutant did not display any activity in mammalian cells (Fillebeen et al., 2005) . The cAcn/IRP1 structure does not shed much light on these processes because both S138 and S711 are inaccessible to solvent. In the case of the latter, a domain opening would be required for it to bind phosphate ( Figure S2 ).
The structure of human cAcn reported here allowed us to identify some of the special features that make this protein so functionally unusual among the Fe-S isomerase family. Indeed, the very similar structural organization of mAcn and cAcn does not justify by itself a major difference between these two molecules. However, most of the insertions scattered along the IRP1 sequence occur at the surface of the molecule, and they significantly change the general shape of cAcn and hence its potential interaction with partners, when compared to mAcn ( Figures 1B and 1C) . Many of these features are directly involved in the predicted interaction with IRE (Figure 4) . Consequently, the present study may be useful for understanding the molecular basis of pathological defects observed upon IRE mutations that lead to cases of hyperferritinemia-cataract syndrome (Levi et al., 1998) and iron overload (Kato et al., 2001 ). Thus, it may be a first step toward the development of potential structure-based therapies against the many iron homeostasis-related disorders (Hentze et al., 2004; Pantopoulos, 2004) .
Experimental Procedures
Structure Determination Three crystals of human IRP1 (Table 4) were used to collect all X-ray data, as described (Dupuy et al., 2005) . Solution of anomalous difference Patterson maps of the C222 1 form with SHELXD (Schneider and Sheldrick, 2002) indicated the presence of one Fe and one Zn site in the native crystal and, in addition, a major and minor gold cluster as a single heavy atom with a B factor of 80 Å 2 . The first 2.9 Å resolution electron density map was of sufficient quality to distinguish protein from solvent zones, and a partially interpretable map could be obtained after solvent flattening with the program SOLOMON (Abrahams and Leslie, 1996; CCP4, 1994) .
A very incomplete first model was constructed automatically with the program RESOLVE (Terwilliger, 2000) . Subsequent chain tracing, performed manually with the graphics program TURBO (Roussel and Cambillaud, 1989) , was greatly facilitated by a superposition of the 1.8 Å resolution model of bovine mitochondrial aconitase (Lloyd et al., 1999) to the electron density map. Further phasing with SHARP, including model phases, allowed for the construction of an 82% complete model. This was used for molecular replacement into the monoclinic crystal form with the program PHASER (Read, 2001) . The model was further improved in the resulting 2.5 Å resolution electron density map of the P2 1 form and, finally, was back transformed to and completed in the C222 1 form.
Refinement
A low-resolution data cutoff of 8 Å was used for initial partial model refinements with REFMAC (CCP4, 1994; Murshudov et al., 1997) . Once a complete atomic model was obtained, a Babinet model for bulk solvent was included, and all the data were incorporated in the refinement, excluding 5% for R free calculations. Atomic positions and isotropic B factors were refined for both crystal forms. In addition, noncrystallographic symmetry restraints and translation libration screw parameters (Winn et al., 2001) were used for each of the structural domains of the two IRP1 molecules in the P2 1 crystal form. A PROCHECK analysis (Laskowski et al., 1993) showed that the model was of high quality, as indicated by the distribution of the main chain angles of more than 90% of the residues in the most favored regions of the Ramachandran plot for the C222 1 crystal form (data not shown). The final refinement statistics are given in Table 2 .
Model Analyses
Superposition of the various structures was performed with the program SUPPOS from the BIOMOL package (http://www.xray.chem. rug.nl/Links/Biomol1.htm). MOLSCRIPT (Kraulis, 1991) , CONSCRIPT (Lawrence and Bourke, 2000) , CAVENV (CCP4, 1994) , RASTER3D (Merritt and Bacon, 1997), and PyMOL (DeLano, 2002) , which was used for electrostatic potential calculations, were used to generate figures.
Supplemental Data
Supplemental Data including an additional figure of the fold of human cytosolic aconitase, an electron density figure of the S711 phosphorylation site, and an additional paragraph supporting the iron-responsive element docking model are available at http:// www.structure.org/cgi/content/full/14/1/129/DC1/.
